Colchicine suppresses atrial fibrillation in failing heart

Rahul Singhal, Shih Lin Chang, Eric Chong, Ya Wen Hsiao, Shuen Hsin Liu, Yung Nan Tsai, Chiao Po Hsu, Yenn Jiang Lin, Li Wei Lo, Trung Le Ha, Yao Chang Chen, Yi-Jen Chen, Chuen Wang Chiou, Shih Ann Chen

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background This study aimed to investigate the mechanism by which colchicine suppresses atrial fibrillation (AF) in a rabbit heart failure (HF) model.

Methods and results HF was induced by coronary ligation. Using the Langendorff perfusion system, monophasic action potentials were recorded in the left atrial appendage (LAA) of normal rabbits (n = 6) and HF rabbits (n = 6) treated with colchicine (100 μM) followed by colchicine (100 μM) plus paclitaxel (5 μM). Collagen content and mRNA and protein expression of ion channels through the PI3K/AKT/eNOS signaling pathway were evaluated in LAA of normal rabbits (n = 6) and HF rabbits treated with vehicle (n = 6) or colchicine (n = 6) intraperitoneal injection for 2 days. Colchicine decreased action potential duration (74.1 ± 2.6 vs 91.8 ± 3.3 ms, P <0.001), effective refractory period, and maximum slope of the restitution curve in HF LAA. However, these effects were reversed by paclitaxel. The incidence of early afterdepolarizations, delayed afterdepolarizations, and AF inducibility was significantly lower after colchicine perfusion than at baseline or after colchicine plus paclitaxel perfusion. Cardiac function increased and LA fibrosis decreased after colchicine treatment. mRNA and protein expression of Kir2.1, Kv1.4, Kv1.5, Kv7.1, Cav1.2, and SERCA2a were upregulated after colchicine treatment, as was mRNA expression of PI3K, AKT, and eNOS. Conclusion Colchicine regulates ion channel gene expression and activates the PI3K/AKT/eNOS signaling pathway in HF rabbits, which may reverse atrial remodeling and suppress AF.

Original languageEnglish
Pages (from-to)651-660
Number of pages10
JournalInternational Journal of Cardiology
Volume176
Issue number3
DOIs
Publication statusPublished - Oct 20 2014

Fingerprint

Colchicine
Atrial Fibrillation
Heart Failure
Rabbits
Atrial Appendage
Paclitaxel
Phosphatidylinositol 3-Kinases
Perfusion
Ion Channels
Messenger RNA
Action Potentials
Atrial Remodeling
Intraperitoneal Injections
Ligation
Proteins
Fibrosis
Collagen
Gene Expression
Incidence

Keywords

  • Atrial fibrillation
  • Colchicine
  • Heart failure
  • PI3K/AKT/eNOS
  • Taxol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Singhal, R., Chang, S. L., Chong, E., Hsiao, Y. W., Liu, S. H., Tsai, Y. N., ... Chen, S. A. (2014). Colchicine suppresses atrial fibrillation in failing heart. International Journal of Cardiology, 176(3), 651-660. https://doi.org/10.1016/j.ijcard.2014.07.069

Colchicine suppresses atrial fibrillation in failing heart. / Singhal, Rahul; Chang, Shih Lin; Chong, Eric; Hsiao, Ya Wen; Liu, Shuen Hsin; Tsai, Yung Nan; Hsu, Chiao Po; Lin, Yenn Jiang; Lo, Li Wei; Ha, Trung Le; Chen, Yao Chang; Chen, Yi-Jen; Chiou, Chuen Wang; Chen, Shih Ann.

In: International Journal of Cardiology, Vol. 176, No. 3, 20.10.2014, p. 651-660.

Research output: Contribution to journalArticle

Singhal, R, Chang, SL, Chong, E, Hsiao, YW, Liu, SH, Tsai, YN, Hsu, CP, Lin, YJ, Lo, LW, Ha, TL, Chen, YC, Chen, Y-J, Chiou, CW & Chen, SA 2014, 'Colchicine suppresses atrial fibrillation in failing heart', International Journal of Cardiology, vol. 176, no. 3, pp. 651-660. https://doi.org/10.1016/j.ijcard.2014.07.069
Singhal R, Chang SL, Chong E, Hsiao YW, Liu SH, Tsai YN et al. Colchicine suppresses atrial fibrillation in failing heart. International Journal of Cardiology. 2014 Oct 20;176(3):651-660. https://doi.org/10.1016/j.ijcard.2014.07.069
Singhal, Rahul ; Chang, Shih Lin ; Chong, Eric ; Hsiao, Ya Wen ; Liu, Shuen Hsin ; Tsai, Yung Nan ; Hsu, Chiao Po ; Lin, Yenn Jiang ; Lo, Li Wei ; Ha, Trung Le ; Chen, Yao Chang ; Chen, Yi-Jen ; Chiou, Chuen Wang ; Chen, Shih Ann. / Colchicine suppresses atrial fibrillation in failing heart. In: International Journal of Cardiology. 2014 ; Vol. 176, No. 3. pp. 651-660.
@article{d465b2de4f304fe58e51f80c65633648,
title = "Colchicine suppresses atrial fibrillation in failing heart",
abstract = "Background This study aimed to investigate the mechanism by which colchicine suppresses atrial fibrillation (AF) in a rabbit heart failure (HF) model.Methods and results HF was induced by coronary ligation. Using the Langendorff perfusion system, monophasic action potentials were recorded in the left atrial appendage (LAA) of normal rabbits (n = 6) and HF rabbits (n = 6) treated with colchicine (100 μM) followed by colchicine (100 μM) plus paclitaxel (5 μM). Collagen content and mRNA and protein expression of ion channels through the PI3K/AKT/eNOS signaling pathway were evaluated in LAA of normal rabbits (n = 6) and HF rabbits treated with vehicle (n = 6) or colchicine (n = 6) intraperitoneal injection for 2 days. Colchicine decreased action potential duration (74.1 ± 2.6 vs 91.8 ± 3.3 ms, P <0.001), effective refractory period, and maximum slope of the restitution curve in HF LAA. However, these effects were reversed by paclitaxel. The incidence of early afterdepolarizations, delayed afterdepolarizations, and AF inducibility was significantly lower after colchicine perfusion than at baseline or after colchicine plus paclitaxel perfusion. Cardiac function increased and LA fibrosis decreased after colchicine treatment. mRNA and protein expression of Kir2.1, Kv1.4, Kv1.5, Kv7.1, Cav1.2, and SERCA2a were upregulated after colchicine treatment, as was mRNA expression of PI3K, AKT, and eNOS. Conclusion Colchicine regulates ion channel gene expression and activates the PI3K/AKT/eNOS signaling pathway in HF rabbits, which may reverse atrial remodeling and suppress AF.",
keywords = "Atrial fibrillation, Colchicine, Heart failure, PI3K/AKT/eNOS, Taxol",
author = "Rahul Singhal and Chang, {Shih Lin} and Eric Chong and Hsiao, {Ya Wen} and Liu, {Shuen Hsin} and Tsai, {Yung Nan} and Hsu, {Chiao Po} and Lin, {Yenn Jiang} and Lo, {Li Wei} and Ha, {Trung Le} and Chen, {Yao Chang} and Yi-Jen Chen and Chiou, {Chuen Wang} and Chen, {Shih Ann}",
year = "2014",
month = "10",
day = "20",
doi = "10.1016/j.ijcard.2014.07.069",
language = "English",
volume = "176",
pages = "651--660",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Colchicine suppresses atrial fibrillation in failing heart

AU - Singhal, Rahul

AU - Chang, Shih Lin

AU - Chong, Eric

AU - Hsiao, Ya Wen

AU - Liu, Shuen Hsin

AU - Tsai, Yung Nan

AU - Hsu, Chiao Po

AU - Lin, Yenn Jiang

AU - Lo, Li Wei

AU - Ha, Trung Le

AU - Chen, Yao Chang

AU - Chen, Yi-Jen

AU - Chiou, Chuen Wang

AU - Chen, Shih Ann

PY - 2014/10/20

Y1 - 2014/10/20

N2 - Background This study aimed to investigate the mechanism by which colchicine suppresses atrial fibrillation (AF) in a rabbit heart failure (HF) model.Methods and results HF was induced by coronary ligation. Using the Langendorff perfusion system, monophasic action potentials were recorded in the left atrial appendage (LAA) of normal rabbits (n = 6) and HF rabbits (n = 6) treated with colchicine (100 μM) followed by colchicine (100 μM) plus paclitaxel (5 μM). Collagen content and mRNA and protein expression of ion channels through the PI3K/AKT/eNOS signaling pathway were evaluated in LAA of normal rabbits (n = 6) and HF rabbits treated with vehicle (n = 6) or colchicine (n = 6) intraperitoneal injection for 2 days. Colchicine decreased action potential duration (74.1 ± 2.6 vs 91.8 ± 3.3 ms, P <0.001), effective refractory period, and maximum slope of the restitution curve in HF LAA. However, these effects were reversed by paclitaxel. The incidence of early afterdepolarizations, delayed afterdepolarizations, and AF inducibility was significantly lower after colchicine perfusion than at baseline or after colchicine plus paclitaxel perfusion. Cardiac function increased and LA fibrosis decreased after colchicine treatment. mRNA and protein expression of Kir2.1, Kv1.4, Kv1.5, Kv7.1, Cav1.2, and SERCA2a were upregulated after colchicine treatment, as was mRNA expression of PI3K, AKT, and eNOS. Conclusion Colchicine regulates ion channel gene expression and activates the PI3K/AKT/eNOS signaling pathway in HF rabbits, which may reverse atrial remodeling and suppress AF.

AB - Background This study aimed to investigate the mechanism by which colchicine suppresses atrial fibrillation (AF) in a rabbit heart failure (HF) model.Methods and results HF was induced by coronary ligation. Using the Langendorff perfusion system, monophasic action potentials were recorded in the left atrial appendage (LAA) of normal rabbits (n = 6) and HF rabbits (n = 6) treated with colchicine (100 μM) followed by colchicine (100 μM) plus paclitaxel (5 μM). Collagen content and mRNA and protein expression of ion channels through the PI3K/AKT/eNOS signaling pathway were evaluated in LAA of normal rabbits (n = 6) and HF rabbits treated with vehicle (n = 6) or colchicine (n = 6) intraperitoneal injection for 2 days. Colchicine decreased action potential duration (74.1 ± 2.6 vs 91.8 ± 3.3 ms, P <0.001), effective refractory period, and maximum slope of the restitution curve in HF LAA. However, these effects were reversed by paclitaxel. The incidence of early afterdepolarizations, delayed afterdepolarizations, and AF inducibility was significantly lower after colchicine perfusion than at baseline or after colchicine plus paclitaxel perfusion. Cardiac function increased and LA fibrosis decreased after colchicine treatment. mRNA and protein expression of Kir2.1, Kv1.4, Kv1.5, Kv7.1, Cav1.2, and SERCA2a were upregulated after colchicine treatment, as was mRNA expression of PI3K, AKT, and eNOS. Conclusion Colchicine regulates ion channel gene expression and activates the PI3K/AKT/eNOS signaling pathway in HF rabbits, which may reverse atrial remodeling and suppress AF.

KW - Atrial fibrillation

KW - Colchicine

KW - Heart failure

KW - PI3K/AKT/eNOS

KW - Taxol

UR - http://www.scopus.com/inward/record.url?scp=84908205244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908205244&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2014.07.069

DO - 10.1016/j.ijcard.2014.07.069

M3 - Article

C2 - 25164186

AN - SCOPUS:84908205244

VL - 176

SP - 651

EP - 660

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -